Home

Onesource Specialty Pharma Ltd Quarterly Result

Image

OneSource Specialty Pharma Ltd

NSE: ONESOURCE

Net Profit - Last Quarter

₹ -39.08 Cr.

Last updated on: Jan 28, 2025

OneSource Specialty Pharma Ltd Quarterly Results Key Highlights

  • The revenue of OneSource Specialty Pharma Ltd for the Sep '24 is ₹ 68.56 crore as compare to the Jun '24 revenue of ₹ 79.6 crore.
  • This represent the decline of -13.87%a1# The ebitda of OneSource Specialty Pharma Ltd for the Sep '24 is ₹ 0.71 crore as compare to the Jun '24 ebitda of ₹ 6.63 crore.
  • This represent the decline of -89.29%a1# The net profit of OneSource Specialty Pharma Ltd for the Sep '24 is ₹ -39.08 crore as compare to the Jun '24 net profit of ₹ -32.83 crore.
  • This represent the growth of 19.04%a1#.

OneSource Specialty Pharma Ltd Quarterly Results Analysis

Market Price of OneSource Specialty Pharma Ltd

1M

1Y

3Y

5Y

Monitoring OneSource Specialty Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Jan 20251536.6
27 Jan 20251617.45
24 Jan 20251702.55

Historical Revenue of OneSource Specialty Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of OneSource Specialty Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of OneSource Specialty Pharma Ltd

No data available

* All values are in crore

OneSource Specialty Pharma Ltd News Hub

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 Januar

Read more

25 Jan 25

Shares of Onesource Specialty Pharma list in T Group

The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January

Read more

24 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of OneSource Specialty Pharma Ltd

What key financial metrics are included in OneSource Specialty Pharma Ltd's quarterly results?

Key financial metrics in OneSource Specialty Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does OneSource Specialty Pharma Ltd announce its quarterly results?

OneSource Specialty Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does OneSource Specialty Pharma Ltd's quarterly performance impact its stock price?

OneSource Specialty Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of OneSource Specialty Pharma Ltd's quarterly results on dividends?

The impact of OneSource Specialty Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during OneSource Specialty Pharma Ltd's quarterly results?

Yes, OneSource Specialty Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions